TradingKey

关于 Neogenomics Inc 公司

NeoGenomics, Inc. 提供一系列肿瘤诊断测试和咨询服务，包括技术实验室服务。该公司由专门从事病理学和肿瘤学的执业医师提供对实验室测试结果的专业解释。其部门包括临床服务和高级诊断。临床服务部门包括临床癌症检测；解释和咨询服务；分子和 NGS 检测，以及全面的技术和专业服务。其临床服务客户包括社区病理学和肿瘤学诊所、医院病理学实验室、参考实验室和学术中心。高级诊断部门包括临床试验和研究、验证实验室服务和信息学。其高级诊断客户包括制药公司，该公司为其提供测试和其他服务以支持其研究和临床试验。

公司简介

公司代码NEO

公司名称Neogenomics Inc

上市日期Dec 10, 2012

CEOMr. Antony P. Zook

员工数量2200

证券类型Ordinary Share

年结日Dec 10

公司地址9490 Neogenomics Way

城市FORT MYERS

上市交易所NASDAQ Capital Market Consolidated

国家United States of America

邮编33912

电话12397680600

网址https://neogenomics.com/

公司代码NEO

上市日期Dec 10, 2012

CEOMr. Antony P. Zook

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

166.66K

+21.81%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Elizabeth Floegel

Independent Director

23.59K

+108.10%

Ms. Felicia Williams

Independent Director

7.16K

--

Ms. Marjorie C. Green

Independent Director

--

Mr. David B. Perez

Independent Director

--

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

--

Mr. Michael A. Kelly

Lead Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

166.66K

+21.81%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Elizabeth Floegel

Independent Director

23.59K

+108.10%

Ms. Felicia Williams

Independent Director

7.16K

--

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Clinical Services-Client direct billing

122.04M

72.63%

Clinical Services-Commercial Insurance

24.86M

14.79%

Clinical Services-Medicare and Medicaid

21.10M

12.56%

Clinical Services-Self-Pay

39.00K

0.02%

暂无数据

业务

地区

业务USD

名称

营收

占比

Clinical Services-Client direct billing

122.04M

72.63%

Clinical Services-Commercial Insurance

24.86M

14.79%

Clinical Services-Medicare and Medicaid

21.10M

12.56%

Clinical Services-Self-Pay

39.00K

0.02%

股东统计

更新时间: 5月14日周三

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

14.16%

The Vanguard Group, Inc.

11.01%

First Light Asset Management, LLC

4.68%

Janus Henderson Investors

4.44%

State Street Global Advisors (US)

3.94%

Other

61.77%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

14.16%

The Vanguard Group, Inc.

11.01%

First Light Asset Management, LLC

4.68%

Janus Henderson Investors

4.44%

State Street Global Advisors (US)

3.94%

Other

61.77%

股东类型

持股股东

占比

Investment Advisor

50.11%

Investment Advisor/Hedge Fund

37.15%

Hedge Fund

7.37%

Research Firm

1.52%

Individual Investor

1.19%

Pension Fund

1.13%

Bank and Trust

0.58%

Sovereign Wealth Fund

0.39%

Insurance Company

0.04%

Other

0.51%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

569

127.92M

99.03%

-12.74M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

2023Q2

691

121.76M

95.45%

-23.63M

2023Q1

704

120.14M

94.21%

-27.80M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

18.29M

14.21%

-356.84K

-1.91%

Mar 31, 2025

The Vanguard Group, Inc.

14.23M

11.06%

+17.23K

+0.12%

Mar 31, 2025

First Light Asset Management, LLC

6.04M

4.7%

+2.88M

+90.77%

Mar 31, 2025

Janus Henderson Investors

5.74M

4.46%

-424.04K

-6.88%

Mar 31, 2025

State Street Global Advisors (US)

5.09M

3.95%

-109.12K

-2.10%

Mar 31, 2025

Greenhouse Funds LLLP

4.71M

3.66%

+6.43K

+0.14%

Mar 31, 2025

Macquarie Investment Management

4.68M

3.63%

+864.39K

+22.67%

Mar 31, 2025

Schroder Investment Management North America Inc.

4.31M

3.35%

+509.99K

+13.42%

Mar 31, 2025

Brown Advisory

3.87M

3.01%

-2.28M

-37.10%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

3.85M

2.99%

+408.27K

+11.88%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

SPDR S&P Health Care Services ETF

1.78%

Invesco S&P SmallCap Health Care ETF

0.67%

WisdomTree BioRevolution Fund

0.63%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.34%

iShares U.S. Healthcare Providers ETF

0.15%

Inspire Small/Mid Cap ESG ETF

0.15%

Federated Hermes MDT Small Cap Core ETF

0.12%

Nuveen ESG Small-Cap ETF

0.09%

iShares ESG Select Screened S&P Small-Cap ETF

0.08%

SPDR S&P 600 Small Cap Value ETF

0.08%

SPDR S&P Health Care Services ETF

占比1.78%

Invesco S&P SmallCap Health Care ETF

占比0.67%

WisdomTree BioRevolution Fund

占比0.63%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比0.34%

iShares U.S. Healthcare Providers ETF

占比0.15%

Inspire Small/Mid Cap ESG ETF

占比0.15%

Federated Hermes MDT Small Cap Core ETF

占比0.12%

Nuveen ESG Small-Cap ETF

占比0.09%

iShares ESG Select Screened S&P Small-Cap ETF

占比0.08%

SPDR S&P 600 Small Cap Value ETF

占比0.08%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Neogenomics Inc

5.595USD

Neogenomics Inc

5.595

概览

公司

财务